In the future, the most effective molecular drugs for directly targeting glutamine, glutaminase, or transporter inhibitors will provide new ideas and methods for treating adverse prognoses such as tumour metastasis, which will bring substantial and effective assistance to the field of tumour cell metastasis inhibition through metabolism. This evidence concerns the gene GLS and neoplasm.